Menu
GeneBe

7-71132984-A-G

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_022479.3(GALNT17):c.182A>G(p.Asp61Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,608,392 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00066 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0013 ( 2 hom. )

Consequence

GALNT17
NM_022479.3 missense

Scores

4
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.21
Variant links:
Genes affected
GALNT17 (HGNC:16347): (polypeptide N-acetylgalactosaminyltransferase 17) This gene encodes an N-acetylgalactosaminyltransferase. This gene is located centromeric to the common deleted region in Williams-Beuren syndrome (WBS), a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.23. This protein may play a role in membrane trafficking. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.029988825).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GALNT17NM_022479.3 linkuse as main transcriptc.182A>G p.Asp61Gly missense_variant 1/11 ENST00000333538.10
GALNT17XM_011516467.4 linkuse as main transcriptc.182A>G p.Asp61Gly missense_variant 1/10
GALNT17XM_017012521.3 linkuse as main transcriptc.182A>G p.Asp61Gly missense_variant 1/7
GALNT17XM_011516469.4 linkuse as main transcriptc.182A>G p.Asp61Gly missense_variant 1/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GALNT17ENST00000333538.10 linkuse as main transcriptc.182A>G p.Asp61Gly missense_variant 1/111 NM_022479.3 P1

Frequencies

GnomAD3 genomes
AF:
0.000658
AC:
100
AN:
152026
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00109
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000668
AC:
159
AN:
237898
Hom.:
0
AF XY:
0.000761
AC XY:
99
AN XY:
130176
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000293
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000331
Gnomad FIN exome
AF:
0.000108
Gnomad NFE exome
AF:
0.00135
Gnomad OTH exome
AF:
0.000340
GnomAD4 exome
AF:
0.00130
AC:
1896
AN:
1456252
Hom.:
2
Cov.:
32
AF XY:
0.00122
AC XY:
885
AN XY:
724538
show subpopulations
Gnomad4 AFR exome
AF:
0.000150
Gnomad4 AMR exome
AF:
0.000292
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.000160
Gnomad4 NFE exome
AF:
0.00165
Gnomad4 OTH exome
AF:
0.000648
GnomAD4 genome
AF:
0.000657
AC:
100
AN:
152140
Hom.:
0
Cov.:
34
AF XY:
0.000618
AC XY:
46
AN XY:
74380
show subpopulations
Gnomad4 AFR
AF:
0.000289
Gnomad4 AMR
AF:
0.000719
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.00109
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00120
Hom.:
0
Bravo
AF:
0.000748
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000932
AC:
8
ExAC
AF:
0.000639
AC:
77
EpiCase
AF:
0.00125
EpiControl
AF:
0.00148

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 15, 2021The c.182A>G (p.D61G) alteration is located in exon 1 (coding exon 1) of the WBSCR17 gene. This alteration results from a A to G substitution at nucleotide position 182, causing the aspartic acid (D) at amino acid position 61 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.26
Cadd
Pathogenic
26
Dann
Uncertain
0.99
DEOGEN2
Benign
0.043
T
Eigen
Benign
-0.029
Eigen_PC
Benign
0.16
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.0098
T
MetaRNN
Benign
0.030
T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-0.92
N
REVEL
Benign
0.14
Sift
Benign
0.056
T
Sift4G
Uncertain
0.048
D
Polyphen
0.020
B
Vest4
0.36
MVP
0.67
MPC
0.80
ClinPred
0.085
T
GERP RS
5.0
Varity_R
0.23
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139969494; hg19: chr7-70597970; API